150 related articles for article (PubMed ID: 22241105)
21. BRCA1/2 test results impact risk management attitudes, intentions, and uptake.
O'Neill SC; Valdimarsdottir HB; Demarco TA; Peshkin BN; Graves KD; Brown K; Hurley KE; Isaacs C; Hecker S; Schwartz MD
Breast Cancer Res Treat; 2010 Dec; 124(3):755-64. PubMed ID: 20383578
[TBL] [Abstract][Full Text] [Related]
22. The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington's disease in the Netherlands (1998-2008).
van Rij MC; de Koning Gans PA; van Belzen MJ; Roos RA; Geraedts JP; De Rademaeker M; Bijlsma EK; de Die-Smulders CE
Clin Genet; 2014 Jan; 85(1):87-95. PubMed ID: 23350580
[TBL] [Abstract][Full Text] [Related]
23. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
Maheu C; Bouhnik AD; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Berthet P; Fricker JP; Caron O; Luporsi E; Gladieff L; Julian-Reynier C
Psychooncology; 2014 Apr; 23(4):420-7. PubMed ID: 24127257
[TBL] [Abstract][Full Text] [Related]
24. Reproductive Endocrinologists' Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers.
Goetsch AL; Wicklund C; Clayman ML; Woodruff TK
J Genet Couns; 2016 Jun; 25(3):561-71. PubMed ID: 26567039
[TBL] [Abstract][Full Text] [Related]
25. Familial communication and cascade testing among relatives of BRCA population screening participants.
Lieberman S; Lahad A; Tomer A; Koka S; BenUziyahu M; Raz A; Levy-Lahad E
Genet Med; 2018 Nov; 20(11):1446-1454. PubMed ID: 29595811
[TBL] [Abstract][Full Text] [Related]
26. Preimplantation genetic diagnosis for BRCA1/2--a novel clinical experience.
Sagi M; Weinberg N; Eilat A; Aizenman E; Werner M; Girsh E; Siminovsky Y; Abeliovich D; Peretz T; Simon A; Laufer N
Prenat Diagn; 2009 May; 29(5):508-13. PubMed ID: 19248143
[TBL] [Abstract][Full Text] [Related]
27. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
[TBL] [Abstract][Full Text] [Related]
28. French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing.
Maheu C; Apostolidis T; Petri-Cal A; Mouret-Fourme E; Gauthier-Villars M; Lasset C; Berthet P; Fricker JP; Caron O; Luporsi E; Gladieff L; Noguès C; Julian-Reynier C
Fam Cancer; 2012 Jun; 11(2):269-78. PubMed ID: 22350503
[TBL] [Abstract][Full Text] [Related]
29. Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis.
Douma KF; Aaronson NK; Vasen HF; Verhoef S; Gundy CM; Bleiker EM
Eur J Hum Genet; 2010 Feb; 18(2):186-93. PubMed ID: 19809485
[TBL] [Abstract][Full Text] [Related]
30. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
31. Fertility intentions following testing for a BRCA1 gene mutation.
Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
[TBL] [Abstract][Full Text] [Related]
32. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.
Menon U; Harper J; Sharma A; Fraser L; Burnell M; ElMasry K; Rodeck C; Jacobs I
Hum Reprod; 2007 Jun; 22(6):1573-7. PubMed ID: 17428877
[TBL] [Abstract][Full Text] [Related]
33. BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles.
Shapira M; Raanani H; Feldman B; Srebnik N; Dereck-Haim S; Manela D; Brenghausen M; Geva-Lerner L; Friedman E; Levi-Lahad E; Goldberg D; Perri T; Eldar-Geva T; Meirow D
Fertil Steril; 2015 Nov; 104(5):1162-7. PubMed ID: 26335130
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
Heemskerk-Gerritsen BA; Seynaeve C; van Asperen CJ; Ausems MG; Collée JM; van Doorn HC; Gomez Garcia EB; Kets CM; van Leeuwen FE; Meijers-Heijboer HE; Mourits MJ; van Os TA; Vasen HF; Verhoef S; Rookus MA; Hooning MJ;
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25788320
[TBL] [Abstract][Full Text] [Related]
35. Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants.
Vuković P; Peccatori FA; Massarotti C; Miralles MS; Beketić-Orešković L; Lambertini M
Crit Rev Oncol Hematol; 2021 Jan; 157():103201. PubMed ID: 33333149
[TBL] [Abstract][Full Text] [Related]
36. Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.
van den Broek AJ; van 't Veer LJ; Hooning MJ; Cornelissen S; Broeks A; Rutgers EJ; Smit VT; Cornelisse CJ; van Beek M; Janssen-Heijnen ML; Seynaeve C; Westenend PJ; Jobsen JJ; Siesling S; Tollenaar RA; van Leeuwen FE; Schmidt MK
J Clin Oncol; 2016 Feb; 34(5):409-18. PubMed ID: 26700119
[TBL] [Abstract][Full Text] [Related]
37. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.
Kim D; Kang E; Hwang E; Sun Y; Hwang Y; Yom CK; Kim K; No JH; Kim YB; Kim SW
Fam Cancer; 2013 Dec; 12(4):621-8. PubMed ID: 23504064
[TBL] [Abstract][Full Text] [Related]
39. Attitude of BRCA1/2 mutation carriers towards fertility preservation, family planning and preimplantation genetic testing for primary prevention of breast and ovarian cancer in the next generation.
Nahshon C; Lavie O; Oron G
J Assist Reprod Genet; 2023 Dec; 40(12):2835-2842. PubMed ID: 37751121
[TBL] [Abstract][Full Text] [Related]
40. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]